Briefing Detail Page
Medicaid: The Essentials
Friday, February 13, 2009
As a state-run program with broad federal guidelines, Medicaid covers health and long-term care services for scores of millions of low-income Americans. Conversations are well underway about the role of Medicaid as a vehicle for economic stimulus, and about its role in health coverage expansion proposals. In that context, a grounding in current Medicaid basics will be essential to congressional health staff, reporters covering health issues and others concerned about health coverage.
Who is eligible for Medicaid? How is it administered? What benefits are covered? What is its role in long-term care? What role does the program play for Medicare beneficiaries? How is Medicaid financed? How much of the funding for the program comes from the federal government? How much do states pay for Medicaid and how much discretion do they have in determining who is covered, and for what services?
To address these and related questions, the Alliance for Health Reform and the Kaiser Commission on Medicaid and the Uninsured sponsored a February 13 luncheon briefing. Diane Rowland of the Kaiser Commission provided a basic overview of who Medicaid covers. Barbara Edwards, former Ohio Medicaid director now at Health Management Associates, discussed Medicaid financing and state administrative responsibilities. Andrew Bindman of the University of California, San Francisco, addressed the program's impact on access, as well as service delivery and provider payment and participation issues. Ed Howard of the Alliance and Diane Rowland moderated the discussion.
Ed Howard, Alliance for Health Reform, Moderator
Diane Rowland, Kaiser Commission on Medicaid and the Uninsured, Speaker
Barbara Edwards, Health Management Associates, Speaker
Andrew Bindman, University of California, San Francisco, Speaker
(Click on the camera icon to see a video of the speaker's presentation.)
|Transcript, Event Summary and/or Webcast and Podcast|
Transcript: Medicaid: The Essentials (Adobe Acrobat PDF), 2/13/2009
Event Summary: Medicaid: The Essentials (Word Document), 2/13/2009
Full Webcast/Podcast: Medicaid: The Essentials
|The transcript, full webcast and podcast for this briefing, as well as videos of individual speakers' presentations, are provided by Kaiser Family Foundation.
Diane Rowland Presentation (PowerPoint), 2/13/2009
Andrew Bindman Presentation (PowerPoint), 2/13/2009
Barbara Edwards Presentation (PowerPoint), 2/13/2009
(If you want to download one or more slides from these presentations, contact us at info@allhealth or click here for instructions.)
Agenda (Adobe Acrobat PDF), , 2/13/2009
Source List (Word Document), , 2/13/2009
Speaker Biographies (Adobe Acrobat PDF), , 2/13/2009
Medicaid: The Essentials (Word Document), , 2/13/2009
|Offsite Materials (briefing documents saved on other websites)|
Medicaid Spending Projected to Rise Much Faster than the Economy, Medical News Today, 10/28/2008
The Faces of Medicaid II: Recognizing the Care Needs of People with Multiple Chronic Conditions, Center for Health Care Strategies, 10/15/2007
The 2009 HHS Poverty Guidelines, United States Department of Health and Human Services, 1/23/2009
Long-Term Care: Consumers, Services, and Financing, National Health Policy Forum, 11/28/2008
Mandatory Eligibility Groups, Centers of Medicare and Medicaid Services, 12/14/2005
Optional Eligibility Groups, Centers of Medicare and Medicaid Services, 1/2/2009
State Medicaid Fact Sheets, The Kaiser Family Foundation, 1/1/2009
Medicaid -- Selected Characteristics of Persons Covered: 2006, U.S. Census Bureau, 8/15/2007
2008 Actuarial Report on the Financial Outlook for Medicaid, Centers for Medicare and Medicaid Services, 10/17/2008
Medicaid Enrollment in 50 States, The Kaiser Commission on Medicaid and the Uninsured, 1/15/2008
Family-Related Medicaid Programs Fact Sheet, Florida Department of Children and Families , 3/15/2008
An Overview of Medicaid in North Carolina (Adobe Acrobat PDF),Duke University, 3/15/2005
Medicare/Medicaid Dual Eligibles, Centers for Medicare and Medicaid Services, 11/24/2008
Medicaid: A Primer (Adobe Acrobat PDF),CRS Report for Congress, 1/17/2008
Medicaid: The Federal Medical Assistance Percentage (FMAP), CRS Report for Congress, 1/24/2008
Medicaid A Primer, The Kaiser Family Foundation, 1/1/2009
The Medicaid Program at a Glance, The Kaiser Family Foundation, 11/15/2008
Medicaid and Long-Term Care Services and Supports, The Kaiser Family Foundation, 2/1/2009
Dual Eligibles: Medicaid's Role for Low-Income Medicare Benefic, The Kaiser Family Foundation, 2/1/2009
Barbara Edwards of Health Management Associates, speaker at the Feb. 13 briefing on Medicaid essentials co-sponsored by the Kaiser Commission on Medicaid and the Uninsured.
Alliance Search for New CEO
WASHINGTON, DC (Aug. 3) – Edward F. Howard, founding executive vice president and CEO of the Alliance for Health Reform in Washington, DC, will retire in March 2016. A nationwide search is underway for his successor.
Over the years, the Alliance has presented hundreds of seminars on Capitol Hill and elsewhere, has organized briefings for reporters around the country and has prepared dozens of issue briefs and “toolkits,” as well as a series of highly-regarded sourcebooks for reporters on health policy topics.
Dr. Robert Graham, Chairman of the Board, noted that the search for a new CEO is being coordinated by Association Strategies of Alexandria, Va. Those interested in learning more about this opportunity should email firstname.lastname@example.org or call 703/ 683-0580. You can also view the position profile on their website. The deadline for applications is Monday, October 12.
Toolkit on Biosimilars
The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”
The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.
Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.